Nasal Bridge Pressure Injury Prevention

NCT04761679 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2022-05-19

No results posted yet for this study

Summary

The primary goal of this study is to explore whether applying the Mepilex foam on the nasal bridge directly between the skin and the N95 mask will prevent nasal bridge pressure injury among nursing staff, secondary to long-term ( \>8+ hours) wear time. The secondary goal is to evaluate if using the Mepilex maintains the seal of the mask.

Conditions

  • Pressure Ulcer of Skin
  • Pressure Injury

Interventions

BEHAVIORAL

Applying the Mepilex foam

Mepilex foam will be directly applied on the nasal bridge directly between the skin and the N95 mask.

Sponsors & Collaborators

Principal Investigators

  • Hazel Holder, MSN, RN, ACCNS-AG, CCRN · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-23
Primary Completion
2022-01-04
Completion
2022-01-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04761679 on ClinicalTrials.gov